Published on 5 Sep 2023 on Exec Edge via Yahoo Finance
By Healthcare Edge Editorial Staff
Eterna Therapeutics Inc. (Nasdaq: ERNA), a life science company focused on the potential of mRNA cell engineering, said it appointed Dorothy Clarke to its board of directors.